Kevin C Hazen

Title: Kevin C Hazen: Innovator in Antifungal and Antibacterial Assays

Introduction

Kevin C Hazen is a notable inventor based in Afton, Virginia. He has made significant contributions to the field of microbiology, particularly in the development of assays for testing antifungal and antibacterial agents. His innovative work has the potential to impact various sectors, including healthcare and pharmaceuticals.

Latest Patents

Kevin C Hazen holds a patent for an "Antifungal and antibacterial susceptibility assay." This assay and test kit are designed for testing and quantifying fungal inhibition by antifungal agents. In this assay, inhibition is measured by a reduction in substrate uptake, such as glucose, compared to uninhibited controls. The assay provides a minimum inhibitory concentration value for each antifungal agent, which is crucial for determining effective dosages.

Career Highlights

Throughout his career, Kevin has worked with reputable organizations, including the Research and Development Institute and the University of Virginia Patent Foundation. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in his field.

Collaborations

Kevin has collaborated with notable colleagues, including Jim E Cutler and Marcia H Riesselman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kevin C Hazen's work in developing antifungal and antibacterial assays showcases his dedication to advancing scientific knowledge and improving healthcare solutions. His contributions are invaluable to the ongoing fight against microbial infections.